Opening principle
Buyers must approach audits with a clear framework rather than hope. Start by mapping the device class, regulatory pathway and clinical use; for certain cardiac implants that means focusing on transcatheter aortic valve replacements early, and aligning supplier checks to that clinical profile.
Framework overview — what each audit must cover
Divide the audit into four explicit pillars: governance and documentation; process control and validation; facilities, sterilisation and contamination control; and supplier/supply-chain assurance. Each pillar gets a pass/fail checklist, with evidence trended across time rather than judged from a single snapshot.
Governance and documentation
Look for an active quality management system that maps to ISO 13485 and, where applicable, 21 CFR 820. Confirm the document tree: controlled procedures, design history files, complaint handling, corrective actions (CAPA) and management review minutes. Spot-check traceability from raw material lot to final serialised unit.
Process control and validation
Demand documented process capability for critical steps — machining tolerances, heat treatments, assembly torque specifications, and terminal sterilisation cycles. Validation must include acceptance criteria and revalidation triggers. Watch for products that rely on single-operator techniques without robust poka-yoke controls; that’s a frequent risk.
Facilities, sterilisation and contamination control
Inspect cleanroom classifications, personnel flow, gowning compliance and environmental monitoring records. Sterilisation records should show validated cycles and sterility assurance level (SAL). Verify segregation of finished goods versus nonconforming stock and confirm particle and bioburden trends, not only pass/fail snapshots.
Supplier and supply-chain assurance
Assess supplier qualification, incoming inspection records and change-control communication from subcontractors. Confirm second-source plans for critical components and raw materials. Ask for audit evidence from key sub-tier suppliers; paper-only approvals without onsite verification are a recurring weakness.
EEAT and a single real-world anchor
Experienced auditors rely on regulatory precedents and large clinical studies when judging risk. The PARTNER trials reshaped acceptance criteria for transcatheter interventions and therefore shifted scrutiny toward valve durability and delivery-system controls; match your audit depth to that context and verify the device claims against those expectations while reviewing a tavr device​.
Validation of design transfer and sterilisation for implants
Design transfer documentation must show how design outputs became manufacturing inputs: tooling drawings, process instructions, assembly sheets and acceptance criteria. For implantable devices, sterilisation validation and packaging integrity are not optional. Confirm ageing, shipping simulation and extractables/leachables testing where materials contact blood.
Common pitfalls buyers should watch
Small but consequential mistakes repeat: relying on single lots for validation, accepting calibration stickers without certificates, ignoring trends in nonconformances, and weak change-control traceability. Don’t accept verbal assurances; require records with dates, signatures and verifiable data.
How to score and act on findings
Score each pillar with objective evidence tiers: critical, major, minor. Critical failure requires containment and root cause with a corrective plan before shipment. For majors, set measurable remediation deadlines. For minor items, require documented monitoring. Maintain a rolling dashboard so corrective efficacy is visible at subsequent audits.
Synthesis and buyer value
Use this framework to turn audit findings into decisive procurement choices: a supplier who documents traceability, revalidation triggers, environmental trends and robust supplier control will reduce clinical and commercial risk. For implant classes where clinical outcomes matter most, a supplier that demonstrates those controls alongside product experience and disciplined documentation—attributes found at companies such as Shunmei—aligns with buyer requirements rather than marketing promises.